Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 33, Issue 1, 2015, Pages 27-31

  Sala Farré, Maria Rosa ^a   Arias Varela, César ^a   Recasens Recasens, Assumpta ^a   Simó Sanahuja, Maria ^b   Muñoz Almagro, Carmen ^c   Pérez Jové, Josefa ^b  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b Parc Logístic de Salut   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bordetella pertussis; Epidemiology; Pertussis; Surveillance; Vaccine

Indexed keywords

PERTUSSIS VACCINE; ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CHILD HOSPITALIZATION; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; THROAT CULTURE; ADULT; CONTACT EXAMINATION; EPIDEMIC; FAMILY SIZE; HEALTH SURVEY; ISOLATION AND PURIFICATION; SCHOOL; SECONDARY IMMUNIZATION; SPAIN; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VACCINATION; WHOOPING COUGH; YOUNG ADULT; AGE; BACTERIUM DETECTION; BACTERIUM ISOLATION; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; HEALTH PROGRAM; HOSPITALIZATION; INFECTION CONTROL; LABORATORY TEST; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; FAMILY CHARACTERISTICS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; MALE; POPULATION SURVEILLANCE; SCHOOLS; SPAIN; VACCINATION; VACCINES, ACELLULAR; WHOOPING COUGH; YOUNG ADULT;

EID: 84921433083     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.09.013     Document Type: Article

References (34)

1. American Academy of Pediatrics. In: Pickering LK, editor. Red book: 2012 report of the committee on infectious diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012. p. 553-6. Available from: http://aapredbook.aappublications.org
2. Cherry JD. Historical perspective on pertussis and use of vaccines to prevent it. Microbe. 2007;2:139-44.
3. Barret AS, Ryan A, Breslin A, Cullen L, Murray A, Grogan J, et al. Pertussis outbreak in northwest Ireland, January-June 2010. Euro Surveill. 2010;15:1-5. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19654
4. Centers for Diseases Control and Prevention. Pertussis epidemic - Washington, 2012. MMWR. 2012;61:517-22. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6128a1.htm
5. Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romoc F, Fernando A, Moraga-Llop F, et al. Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina. Enferm Infecc Microbiol Clin. 2013;31:240-53. http://dx.doi.org/10.1016/j.eimc.2012.12.011.
6. Calentano L, Massarl M, Paramatti D, Salmaso S, Tozzi A. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761-5.
7. Vera I, García-Comas L, Ordobas M, Gutierrez A, SanzJC, Barranco D. Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005. Euro Surveill. 2007;12:209-13. Available from: http://w@@ww.eurosurveillance.org/ViewArticle.aspx?ArticleId=731
8. Manzanares S, Lafuente S, Martí M, Simon P, Gorrindo P, Caylà JA. Evolución de la incidencia de tos ferina en la ciudad de Barcelona entre 1999 y 2011. Enferm Infecc Microbiol Clin. 2013;31:156-8.
9. Borràs E, Domínguez A, Batalla J, Torner N, Cardeñosa N, Nebot M. Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine. 2007;25:3240-3.
10. Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, et al. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011;29:4244-8.
11. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L. Temporal tends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis. 2012;18:767-74.
12. Schmidtke AJ, Boney KO, Stacey M, Skoff T, Tondella ML, Tatti K. Population diversity among Bordetella pertussis isolates, United States, 1935-2009. Emerg Infect Dis. 2012;18:1248-55.
13. Stehr K, Cherry JD, Heininger U, Schmitt-Grohe S, Uberall M, Laussucq S, et al. A comparative efficacy trial in Germany in infants who receive either the Lederle/ Takeda acellular pertussis component DTP (DTaP) vaccine, or DT vaccine. Pediatrics. 1998;101:1-11.
14. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161:1091-6.
15. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54:1730-5.
16. European Centre for Disease Control. ECDC technical document. Guidance and protocol for the use of realtime PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis; 2012. Available from: http://www.ecdc.europa.eu/en/publications/technical-documents/Pages/index.aspx
17. Chan MH, Ma L, Sidelinger D, Bethel L, Yen J, Inveiss A, et al. The California pertussis epidemic 2010: a review of 986 pediatric case reports from San Diego County. J Pediatr Infect Dis. 2012;1:47-54.
18. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367:1012-9.
19. Tartof S, Lewis M, Kenyon C, White K, Osborn A, Liko J, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013, http://dx.doi.org/10.1542/peds.2012-1928. Available from: http://pediatrics.aappublications.org/content/early/2013/03/06/peds.2012-1928.full.pdf+html (published online: 11.03.13).
20. Witt M, Larry A, Katz P, Elizabeth T, Truong E, Witt D. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US Cohort. Clin Infect Dis. 2013;56:1248-54.
21. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005;115:1422-7.
22. Centers for Diseases Control and Prevention. Pertussis - United States, 2001-2003. MMWR. 2005;54:1283-6.
23. Lavine J, Broutin H, Harvill ET, Bjornstad O. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine. 2005;29:11-6.
24. Jardine A, Conaty SJ, Lowbridge C, Staff M, Vally H. Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. Commun Dis Intell Q Rep. 2010;34:116-21.
25. Wendeloe AM, Njamkepo E, Bourillon A, Floret D, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293-9.
26. European Centre for Disease Control. ECDC Guidance. Scientific panel on childhood immunization schedule: diphtheria-tetanus-pertussis (DTP) vaccination. Stockholm; 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC DispForm.aspx?ID=458
27. Cherry JD, Tan T, Wirsing von König CH, Forsyth K, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: summary of Global Pertussis Initiative Roundtable Meeting February 2011. Clin Infect Dis. 2012;54:1756-64.
28. Ridda I, Yin JK, King C, MacIntyre CR, McIntyre P. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine. 2012;30:6745-52.
29. Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician. 2006;74:420-6. Available from: http://www.aafp.org/afp/2006/0801/p420.html
30. Clarke MF, Rasiah K, Copland J, Watson M, Koehler A, Dowling K, et al. The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiol Infect. 2013;141:463-71.
31. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Source Rationale for pertussis booster vaccination throughout life in Europe Lancet Infect Dis. 2011;11:557-70.
32. Shinall MC, Peters TR, Zhu Y, Chen Q, Poehling K. Potential impact of acceleration of the pertussi vaccine primary series for infants. Pediatrics. 2008;122:1021-6.
33. Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatrics. 2008;152:655-60.
34. Baraff LJ, Leake RD, Burstyn DG, PayneT, Cody C, Manclark C, et al. Immunologic response to early and routine DTP immunization in infants. Pediatrics. 1984;73:37-42.